InvestorsHub Logo
Followers 14
Posts 1226
Boards Moderated 1
Alias Born 08/16/2009

Re: mlkrborn post# 32

Friday, 01/29/2010 6:44:35 PM

Friday, January 29, 2010 6:44:35 PM

Post# of 40
They have an innovative drug, but some cash problems. If I read the sec filings correctly, the patents expire on their depression drug, so if they want the patents extended, they'll have to find some cash and do some quick clinical trials.

They recently settled w/ one of their creditors, but I'm not sure if there are more creditors remaining or not.

Visit my biotech investing board!: investorshub.advfn.com/boards/board.aspx?board_id=16653



GLTA.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.